Investor Directory

We invest in Health, Wellness, Longevity, Digital Health, Foodtech, Agritech, Fintech

We invest in North American and European fintech and insurtech companies that are raising pre-seed or seed rounds

We invest globally in early stage, highly scalable, breakthrough technology companies

We invest in Fintech, IoT, smartcity, SaaS, EdTech, artificial intelligence

Index's latest fund..

We invest in early-stage startups in cyber security, Digital Health, Fintech, enterprise software and more. Seed stage and Series A.

We invest in US-based pre-seed companies with the potential to create a more sustainable and equitable workforce.

We invest in startups, from Pre-series A to series B, which have innovative potentials in four key impact domains - (1) climate solutions, (2) wellness and healthcare solutions, (3) education solutions, and (4) workstyle solutions.

We invest in B2B high-tech startups

We invest in Tech. But must be doing real engineering. Checks: $100K to $500K. Majority $150K to $300K Total Round Size: $100K - $500K. (Occasional exceptions to $1M.) Valuation: $1M - $3M. (Rare exceptions to $6M with extreme traction.) Traction / Progress: $5K to $30K/month in gross profit. No ideas or prototypes. Headcount: 2+ founders

We invest in enterprise software, digital health, and fintech companies at the pre-seed and seed stage.

We invest in tech-driven pre-seed start-ups in the areas of LogTech, climate tech and related verticals, including commerce, real estate, healthcare, and energy. Backed by FIEGE Logistics, our aim is to provide founders with an unfair advantage through know-how, infrastructure, go-to-market, and fundraising.

LiveOak's third fund..

Venture arm of Yıldız Holding investing $500K–$5M in early-stage consumer goods and food tech startups in Turkey and abroad with 17 investments.

We invest in Pre-Seed and Seed High Growth Markets Fintech. We also consider non-fintech companies where embedded finance has the potential to be 25%+ of the revenue. Evidence of early-traction and SAM are important in my analysis. SAM = # of viable customers x annual customer value.

We invest in impact startups primarily in the Nordics. Investment Themes: Energy Transition, Circularity & Sustainable Food Systems. Investment Stage: Late Seed to Series A.

We invest in Digital Health, Healthtechs, Medical Devices, Medtech, Biotech, Techbio, Diagnostics and other healthcare startups. They need to either reduce healthcare costs or improve clinical outcomes (ideally both), and have advanced clinical trials (in case it is needed).

We invest in B2B SaaS with MVP and above, but can also consider other sectors. We fund Pre-Seed but not ideation stage.

We invest in Blockchain - DeFi, AI, DePin, Layer Solutions, SocialFi, TradeFi, RWA

We invest in US-based software, consumer products, and medical devices.

I invest in SaaS, AI, IOT, Biotech industry. $30K-200K per deal.

I invest in early stage startups in IT and Tech

We invest in Pre-Seed, Seed and Pre-Series A. Our initial tickets are in the €50k-€300k range. We are minority investors and we like to co-invest with other VCs. We are agnostic in terms of business models and sectors, but SaaS models are preferred.

We invest in B2B software with a focus on applications of AI in Fintech, Proptech, Legaltech, Enterprise Software, MarketingTech, Cyber Security, Energy and ClimateTech.

We invest in AI and Blockchain

We invest in Pre seed up to Pre-Series A companies with great & smart founders who have had professional experience within relevant fields. Sector agnostic with a preference for revolutionary tech or early signs of traction.

We invest in US-based Enterprise SaaS, deep-tech, fin-tech, and prop-tech companies.

We invest in US-based B2B companies that transform the way work gets done, such as: Vertical SaaS, Fintech, Future of Work, Dev tools, and Security

We invest in tech-driven businesses which are synergistic to our BUs. We invest typically in companies that are scaling up from $1M ARR onwards with a strong tech positioning

We invest in founders with grit, timely and differentiated business models and a path to both financial scaling and greenhouse gas impact, across all forms of transportation (road, aviation and maritime). We are open to both software and hardware (with a balanced capital stack across equity, debt and grants).

We invest in African tech ventures that are building the digital economy in sectors like Fintech, Edtech, Agtech, Healthtech, Cleantech, etc in Kenya, Ivory Coast, Nigeria, Ghana and South Africa (KINGS) - these countries are the KINGS of Africa's digital economy.

We invest in founders who are one step ahead, building next generation products and services essential to the changing consumer and SMB.

We invest in industry agnostic pre-seed and seed stage startups, and we particularly value the startups founded by Gen-Z in the colleges who "are not eager to become entrepreneurs".

We invest in VN-based founders and companies solving emerging Asia/global problems, or globally-based teams solving for VN/emerging Asia. We are a generalist VC (We look at all sectors) and especially interested in fintech, edtech, future of work, enterprise SaaS, health tech, and logistics. We'd like to be your first institutional VC.

We invest in all sectors, with a particular attention toward GreenTech.

We invest in Late Seed and Series A venture capital financing rounds of software/internet/tech companies. We invest primarily into Enterprise Saas companies, Fintech, Hospitality Tech, Real Estate / PropTech, Workflow Tech, E-commerce, and Omni Channel Consumer Brands. Companies must have at least $1m in ARR.

We invest in solutions improving resource efficiency in the Built Environment, Energy/Electrification, and Transportation & Logistics sectors.

We invest in startups with good revenue growth and a top tier VC on the cap table/leading the round

We invest in software, healthcare and creative content companies. In software space, we prefer B2B business models and ARR of >£750K. In healthcare, we invest in companies across Healthtech, Medtech, Bitoech, Drug Discovery and diagnostics firm across various stages. Our initial cheque size ranges from £1 to £3m and able to fund follow-on rounds.

We invest in tech entrepreneurs from Caucasus, Central Asia, and Eastern Europe

We invest in FinTech, blockchain, entertainment and the creator economy. We invest in early stage; pre-seed, seed and series A. We target investments <$20MM post-money valuation with traction.

We invest in businesses whose principal operations are in Australia or China. We look to expanding Australian businesses into Asia or Asian businesses expanding to Australia. We target an enterprise value of between A$5 million and A$200 million.

We invest in early-stage, founder-led companies solving complex problems in AI infrastructure, GPU compute, fintech, SaaS, automation, defense, space, and deep tech. Our model combines last-in seed capital with rapid hiring, helping founders close their rounds and build high-performing teams within weeks. We back companies where technical execution and talent velocity determine success, typically scaling from 10 to 50 employees and moving from prototype to commercial traction.

We invest in high potential growth scale companies using equity crowd funding. We are licensed by the Securities Commission, Malaysia.

We accelerate and invest in healthtech and biotech startups from the entire LatAm region, from an idea stage to pre-series

We invest in US-based healthcare technology and services company with $100k+ in ARR

I invest in AI/ML and B2B from Global Market, Pre-revenue stage

We invest in seed stage startups with diverse founders building a more inclusive economy with financial innovation.

We invest in digital health companies that benefit healthcare providers and health systems

I invest into exciting tech opty.